Safely protecting
against mosquito-borne
viral diseases

Mosquito-borne pandemic threats are rising all over the world due to climate change and human-led environmental impact

500 mil

Infections per year

> 100 K

Annual deaths

€9 bil

Economic loss

1 flavivaccine

Discover our solution

We are developing a novel vaccination approach to prepare for future emerging epidemics or pandemics caused by flaviviruses.

About

Flavivaccine encompasses the entire research and development process to create a safe and cost-effective vaccine against multiple flaviviruses.

Flavivirus

The public health threat from flaviviruses is becoming increasingly serious worldwide, making urgent and effective protection against them essential.

Last updates

news release - June 16, 2026

FLAVIVACCINE presented at the 9th Asia Dengue Summit in Singapore

FLAVIVACCINE was presented to an international audience at the 9th Asia Dengue Summit, held in Singapore from 15 to 17 June 2026.

project update - April 21, 2026

Progress and next steps: FLAVIVACCINE General Assembly in Fontenay-aux-Roses

Last week, the FLAVIVACCINE consortium gathered in Fontenay-aux-Roses (France) for the project’s latest General Assembly, kindly hosted by CEA.

project update - October 6, 2025

FLAVIVACCINE Consortium held General Assembly to review project’s progress and next steps

The FLAVIVACCINE consortium held its General Assembly online on September 30 and October 2, bringing together partners from across Europe and the U.S. to reflect on recent progress and plan the next steps in the project.

News & Events

Subscribe to the
newsletter